Cargando…

Etiopathogenesis of ovarian cancer. An inflamm-aging entity?

Ovarian cancer is one of the most common gynecologic cancers and has the highest mortality rate. The risk/protective factors of ovarian cancer suggest that its etiology is multifactorial. Several factors are involved in age-related increases in carcinogenesis, including the accumulation of senescent...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Prieto, Manuel, Sánchez-Borrego, Rafael, Lubián-López, Daniel Maria, Pérez-López, Faustino R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198811/
https://www.ncbi.nlm.nih.gov/pubmed/35719320
http://dx.doi.org/10.1016/j.gore.2022.101018
_version_ 1784727723316346880
author Sánchez-Prieto, Manuel
Sánchez-Borrego, Rafael
Lubián-López, Daniel Maria
Pérez-López, Faustino R.
author_facet Sánchez-Prieto, Manuel
Sánchez-Borrego, Rafael
Lubián-López, Daniel Maria
Pérez-López, Faustino R.
author_sort Sánchez-Prieto, Manuel
collection PubMed
description Ovarian cancer is one of the most common gynecologic cancers and has the highest mortality rate. The risk/protective factors of ovarian cancer suggest that its etiology is multifactorial. Several factors are involved in age-related increases in carcinogenesis, including the accumulation of senescent cells, inflammaging (a chronic inflammatory state that persists in the elderly), and immunosenescence (aging of the immune system) changes associated with poor immune surveillance. At sites of inflammation, exposure to high levels of inflammatory mediators, such as reactive oxygen species, cytokines, prostaglandins, and growth factors, contributes to increased cell division and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the proinflammatory tumor microenvironment contributes to ovarian cancer metastasis and chemoresistance. This narrative review of the literature was carried out to delineate the possible role of inflammaging in the etiopathogenesis of ovarian cancer development. We discuss the current carcinogenic hypotheses, sites of origin, and etiological factors of ovarian cancer. Treatment of inflammation may represent an attractive strategy for both the prevention and therapy of ovarian cancer.
format Online
Article
Text
id pubmed-9198811
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91988112022-06-16 Etiopathogenesis of ovarian cancer. An inflamm-aging entity? Sánchez-Prieto, Manuel Sánchez-Borrego, Rafael Lubián-López, Daniel Maria Pérez-López, Faustino R. Gynecol Oncol Rep Review Article Ovarian cancer is one of the most common gynecologic cancers and has the highest mortality rate. The risk/protective factors of ovarian cancer suggest that its etiology is multifactorial. Several factors are involved in age-related increases in carcinogenesis, including the accumulation of senescent cells, inflammaging (a chronic inflammatory state that persists in the elderly), and immunosenescence (aging of the immune system) changes associated with poor immune surveillance. At sites of inflammation, exposure to high levels of inflammatory mediators, such as reactive oxygen species, cytokines, prostaglandins, and growth factors, contributes to increased cell division and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the proinflammatory tumor microenvironment contributes to ovarian cancer metastasis and chemoresistance. This narrative review of the literature was carried out to delineate the possible role of inflammaging in the etiopathogenesis of ovarian cancer development. We discuss the current carcinogenic hypotheses, sites of origin, and etiological factors of ovarian cancer. Treatment of inflammation may represent an attractive strategy for both the prevention and therapy of ovarian cancer. Elsevier 2022-06-11 /pmc/articles/PMC9198811/ /pubmed/35719320 http://dx.doi.org/10.1016/j.gore.2022.101018 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Sánchez-Prieto, Manuel
Sánchez-Borrego, Rafael
Lubián-López, Daniel Maria
Pérez-López, Faustino R.
Etiopathogenesis of ovarian cancer. An inflamm-aging entity?
title Etiopathogenesis of ovarian cancer. An inflamm-aging entity?
title_full Etiopathogenesis of ovarian cancer. An inflamm-aging entity?
title_fullStr Etiopathogenesis of ovarian cancer. An inflamm-aging entity?
title_full_unstemmed Etiopathogenesis of ovarian cancer. An inflamm-aging entity?
title_short Etiopathogenesis of ovarian cancer. An inflamm-aging entity?
title_sort etiopathogenesis of ovarian cancer. an inflamm-aging entity?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198811/
https://www.ncbi.nlm.nih.gov/pubmed/35719320
http://dx.doi.org/10.1016/j.gore.2022.101018
work_keys_str_mv AT sanchezprietomanuel etiopathogenesisofovariancanceraninflammagingentity
AT sanchezborregorafael etiopathogenesisofovariancanceraninflammagingentity
AT lubianlopezdanielmaria etiopathogenesisofovariancanceraninflammagingentity
AT perezlopezfaustinor etiopathogenesisofovariancanceraninflammagingentity